Comparable stake leader
ARMISTICE CAPITAL, LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001231457.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
2/50
Latest evidence
03 Nov 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
Reported 13D/G
· 30 Sep 2025
|
$17,737,763
4,223,277 shares
|
$0 | 30 Sep 2025 |
| Aladar Szalay |
13D/G
3/4/5
10%+ Owner
|
6.2%
Reported 13D/G
· 30 Sep 2026
|
$7,142,852
2,834,465 shares
|
-$755,549 | 30 Sep 2026 |
| WOODWARD DIVERSIFIED CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$6,018,250
2,378,755 shares
|
— | 30 Sep 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$4,202,317
1,660,995 shares
|
— | 30 Sep 2026 |
| Bleichroeder LP |
13F
Company
|
—
denominator unverified
|
$3,493,085
1,380,666 shares
|
— | 30 Sep 2026 |
| Thomas Zindrick |
3/4/5
President and CEO
|
—
mixed-class rows
|
$3,007,848
1,673,338 shares
mixed-class rows
|
-$124,016 | 03 Nov 2026 |
| Qian Zhang |
3/4/5
Associate VP, Research
|
—
denominator unverified
|
$1,978,061
139,533 shares
|
— | 17 Feb 2023 |
| John Thomas |
3/4/5
Director
|
—
mixed-class rows
|
$1,212,887
532,759 shares
mixed-class rows
|
-$108,766 | 16 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$340,565.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 58,828 | $0 | $155,693 | -$155,693 |
| 3-6 | 0 | 26,521 | $0 | $78,014 | -$78,014 |
| 6-9 | 0 | 20,257 | $0 | $56,076 | -$56,076 |
| 9-12 | 0 | 10,165 | $0 | $50,782 | -$50,782 |
Reporting owners
Showing 1-19 of 19 reporting-owner rows connected to GENELUX Corp. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Thomas Zindrick | President and CEO | $3,007,848 | -$124,016 | -4% | Mixed | 03 Nov 2026 |
| Qian Zhang | Associate VP, Research | $1,978,061 | Mixed | 17 Feb 2023 | ||
| Aladar Szalay | 10%+ Owner | $1,553,120 | Mixed | 12 Sep 2024 | ||
| John Thomas | Director | $1,212,887 | -$108,766 | -8.2% | Mixed | 16 Jun 2026 |
| Matthew Pulisic | Chief Financial Officer | $674,952 | Mixed | 16 Jun 2026 | ||
| Joseph Cappello | Chief Technical Officer | $648,431 | -$35,391 | -5.2% | Filing P/S | 03 Nov 2026 |
| Eric Groen | General Counsel | $566,175 | Mixed | 16 Jun 2026 | ||
| Yong Yu | Chief Scientific Officer | $518,955 | -$33,915 | -6.1% | Filing P/S | 03 Nov 2026 |
| John W. Smither | Director | $265,818 | -$34,898 | -12% | Filing P/S | 01 Jul 2026 |
| Mary Mirabelli | Director | $248,517 | Mixed | 16 Jun 2026 | ||
| James L. Tyree | Director | $233,488 | Mixed | 16 Jun 2026 | ||
| Ralph Smalling | Head of Regulatory | $198,100 | -$3,578 | -1.8% | Filing P/S | 03 Jun 2026 |
| Lourie S. Zak | Chief Financial Officer | $192,938 | Mixed | 18 Dec 2024 | ||
| Gabe Woodward | Director | $175,247 | Mixed | 17 Feb 2023 | ||
| Sean Ryder | General Counsel | $139,053 | Filing P/S | 12 May 2025 | ||
| Caroline Jewett | Head of Quality | $34,289 | Filing P/S | 19 Feb 2024 | ||
| Doug Samuelson | Vice President, Finance | Mixed | 11 Sep 2023 | |||
| Paul Scigalla | Chief Medical Officer | Mixed | 18 Oct 2024 | |||
| Jason Litten | Chief Medical Officer | Mixed | 02 Jan 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Joseph Cappello | GNLX | Common Stock | Sale | -0.21% | -$1,363 | $2.04 | -668 | 317,812 | 03 Nov 2026 | Direct |
| Thomas Zindrick | GNLX | Common Stock | Sale | -0.25% | -$6,317 | $2.05 | -3,089 | 1,223,338 | 03 Nov 2026 | Direct |
| Yong Yu | GNLX | Common Stock | Sale | -0.26% | -$1,344 | $2.01 | -668 | 258,020 | 03 Nov 2026 | Direct |
| Joseph Cappello | GNLX | Common Stock | Sale | -3.12% | -$28,112 | $2.74 | -10,257 | 318,480 | 31 Aug 2026 | Direct |
| Thomas Zindrick | GNLX | Common Stock | Sale | -2.73% | -$91,899 | $2.67 | -34,463 | 1,226,427 | 31 Aug 2026 | Direct |
| Yong Yu | GNLX | Common Stock | Sale | -3.61% | -$26,658 | $2.75 | -9,683 | 258,688 | 31 Aug 2026 | Direct |
| Yong Yu | GNLX | Common Stock | Sale | -0.24% | -$1,922 | $2.94 | -653 | 268,371 | 04 Aug 2026 | Direct |
| Joseph Cappello | GNLX | Common Stock | Sale | -0.2% | -$1,924 | $2.95 | -653 | 328,737 | 04 Aug 2026 | Direct |
| Thomas Zindrick | GNLX | Common Stock | Sale | -0.24% | -$8,905 | $2.95 | -3,023 | 1,260,890 | 04 Aug 2026 | Direct |
| John W. Smither | GNLX | Common Stock | Sale | -11.6% | -$34,898 | $2.91 | -12,000 | 91,403 | 01 Jul 2026 | Direct |
| Matthew Pulisic | GNLX | Common Stock | Award | 278,906 | 278,906 | 16 Jun 2026 | Direct | |||
| Eric Groen | GNLX | Common Stock | Award | 233,957 | 233,957 | 16 Jun 2026 | Direct | |||
| Joseph Cappello | GNLX | Common Stock | Award | 113.1% | 174,841 | 329,390 | 16 Jun 2026 | Direct | ||
| James L. Tyree | GNLX | Common Stock | Award | 41.7% | 28,409 | 96,483 | 16 Jun 2026 | Direct | ||
| James L. Tyree | GNLX | Stock Option (Right to Buy) | Award | 31,566 | 31,566 | 16 Jun 2026 | Direct | |||
| Thomas Zindrick | GNLX | Common Stock | Award | 137% | 730,601 | 1,263,913 | 16 Jun 2026 | Direct | ||
| John Thomas | GNLX | Common Stock | Award | 6.01% | 28,409 | 501,193 | 16 Jun 2026 | Direct | ||
| John Thomas | GNLX | Stock Option (Right to Buy) | Award | 31,566 | 31,566 | 16 Jun 2026 | Direct | |||
| Mary Mirabelli | GNLX | Common Stock | Award | 38.2% | 28,409 | 102,693 | 16 Jun 2026 | Direct | ||
| Mary Mirabelli | GNLX | Stock Option (Right to Buy) | Award | 31,566 | 31,566 | 16 Jun 2026 | Direct | |||
| Yong Yu | GNLX | Common Stock | Award | 79.7% | 119,318 | 269,024 | 16 Jun 2026 | Direct | ||
| John W. Smither | GNLX | Common Stock | Award | 37.9% | 28,409 | 103,403 | 16 Jun 2026 | Direct | ||
| John W. Smither | GNLX | Stock Option (Right to Buy) | Award | 31,566 | 31,566 | 16 Jun 2026 | Direct | |||
| Ralph Smalling | GNLX | Common Stock | Sale | -0.28% | -$563 | $2.93 | -192 | 67,611 | 03 Jun 2026 | Direct |
| John Thomas | GNLX | Common Stock | Sale | -2.07% | -$29,801 | $2.98 | -10,000 | 472,784 | 01 Jun 2026 | Direct |
| Yong Yu | GNLX | Common Stock | Sale | -0.4% | -$1,798 | $2.97 | -605 | 149,706 | 11 May 2026 | Direct |
| Joseph Cappello | GNLX | Common Stock | Sale | -0.39% | -$1,799 | $2.97 | -605 | 154,549 | 11 May 2026 | Direct |
| Thomas Zindrick | GNLX | Common Stock | Sale | -0.52% | -$8,226 | $2.94 | -2,798 | 532,051 | 11 May 2026 | Direct |
| Ralph Smalling | GNLX | Common Stock | Sale | -0.4% | -$804 | $2.98 | -270 | 67,803 | 11 May 2026 | Direct |
| Ralph Smalling | GNLX | Common Stock | Sale | -0.35% | -$602 | $2.51 | -240 | 68,073 | 25 Mar 2026 | Direct |
| Ralph Smalling | GNLX | Common Stock | Sale | -0.5% | -$835 | $2.42 | -345 | 68,313 | 24 Mar 2026 | Direct |
| Joseph Cappello | GNLX | Common Stock | Sale | -0.58% | -$2,193 | $2.42 | -906 | 155,154 | 24 Mar 2026 | Direct |
| Yong Yu | GNLX | Common Stock | Sale | -0.62% | -$2,193 | $2.42 | -906 | 144,938 | 24 Mar 2026 | Direct |
| Thomas Zindrick | GNLX | Common Stock | Sale | -0.67% | -$8,668 | $2.42 | -3,582 | 534,849 | 24 Mar 2026 | Direct |
| John Thomas | GNLX | Common Stock | Sale | -2.03% | -$28,957 | $2.90 | -10,000 | 482,784 | 02 Mar 2026 | Direct |
| Jason Litten | GNLX | Stock Option (Right to Buy) | Award | 275,000 | 275,000 | 02 Jan 2026 | Direct | |||
| Ralph Smalling | GNLX | Common Stock | Sale | -0.24% | -$774 | $4.69 | -165 | 68,658 | 05 Dec 2025 | Direct |
| John Thomas | GNLX | Common Stock | Sale | -1.99% | -$50,008 | $5.00 | -10,000 | 492,784 | 01 Dec 2025 | Direct |